PROTARGA

Serial Number 77522205
606

Registration Progress

Application Filed
Jul 15, 2008
Under Examination
Feb 3, 2009
Approved for Publication
Oct 22, 2008
Published for Opposition
Nov 11, 2008
Registered

Trademark Image

PROTARGA

Basic Information

Serial Number
77522205
Filing Date
July 15, 2008
Published for Opposition
November 11, 2008
Abandonment Date
September 7, 2009
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 7, 2009
Classes
005

Rights Holder

Luitpold Pharmaceuticals, Inc.

03
Address
One Luitpold Drive
Shirley, NY 11967

Ownership History

Luitpold Pharmaceuticals, Inc.

Original Applicant
03
Shirley, NY

Luitpold Pharmaceuticals, Inc.

Owner at Publication
03
Shirley, NY

Legal Representation

Attorney
Peter S. Reichertz, Esq.

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Sep 8, 2009 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Sep 7, 2009 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 3, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 11, 2008 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 22, 2008 NPUB O NOTICE OF PUBLICATION Loading...
Oct 9, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 3, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2008 ALIE A ASSIGNED TO LIE Loading...
Sep 8, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 8, 2008 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Aug 28, 2008 MAIL I PAPER RECEIVED Loading...
Aug 21, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 21, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 21, 2008 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 21, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 18, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cancer, antiviral diseases, and neurological disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005